SK Biopharmaceuticals CEO Lee Dong-hoon speaks at a press event on Monday announcing the joint venture formed between the Korean company and Eurofarma in San Francisco. [SK BIOPHARMACEUTICALS] SAN ...

1 Day 326030 0.46% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% ...

SAN FRANCISCO -- SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical companies, to commercialize a new AI-based epilepsy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...